http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0162241-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_942436d0443b7927d9a3b4aa655a4c38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c02fef607178db55f07304ba62d70bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
filingDate 2001-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca9c30c1aaae186be2020c2f4d79f29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce8cf40e01e201ac27eb19662567ab5
publicationDate 2001-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0162241-A1
titleOfInvention Method for the prevention or reduction of vascular access dysfunction
abstract This invention provides a method for the prevention or reduction of vascular access dysfunction in association with the insertion or repair of an indwelling shunt, fistula or catheter into a vein, in a mammal, preferably a human, in need thereof, which comprises administering to the subject N-(3',4'-dimethoxycinnamoyl)anthranilic acid or a pharmaceutically acceptable salt thereof in a dose of from about 0.1 mg to about 2,400 mg.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2226036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006062909-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104751440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007001744-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012176260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007001744-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006062909-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004071532-A1
priorityDate 2000-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6019104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5385935-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128776144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846

Total number of triples: 33.